Sumitomo Chemical India Limited
Sumitomo Chemical India Ltd. (SCIL) is one of the leading players in the industry which has a balanced portfolio of technical as well as formulation products along with backward integration for some products. The Company is known for domestic marketing of proprietary products of its Japanese parent -Sumitomo Chemical Company Limited in agrochemicals, animal nutrition, and environmental health business segments. With…
What Sumitomo files
- Others25
- Investor Meet18
- Important13
- Board Meeting8
- PPTs7
- Results7
Sumitomo Chemical India reported a resilient Q1 performance, with revenue up 1% year-on-year to 1,063 Cr, despite a challenging agrochem market due to monsoon delays. Exports surged 26% to 16% of revenue, boosted by South America and Asia. Operating EBITDA rose 6% to 233 Cr, with margins at 21.9%. Net...
**1. Business Performance:** Sumitomo Chemical India (SCIL) delivered stable FY26 results despite a challenging agrochemical market. Full-year revenue grew 3% to ₹3,238 Cr. Net Profit reached an all-time high, rising 7% to ₹543 Cr, with a 16.8% margin. Domestic business expanded 4%, and Herbicides notably surged 19%. **2. Growth Drivers...
Sumitomo Chemical India (SUMICHEM) reported a mixed Q3FY26. Revenue declined 12% YoY to Rs 568 crore, primarily due to discontinuing a low-margin Animal Nutrition business (Rs 72 crore impact) and weak domestic agri-input demand. Despite this, gross profit margins significantly expanded to 47.4% (up 522 bps) and EBITDA margin improved...
Sumitomo Chemical India (SCIL) reported mixed results. For Q3FY26, revenue fell 12% to Rs 568 Cr, with profit after tax (PAT) down 13% to Rs 76 Cr, primarily due to discontinuing Animal Nutrition products and soft domestic demand. Despite this, gross margin expanded to 47.4% and EBITDA margin to 17.5%...
Sumitomo Chemical India's Q2FY26 results showed a 6% revenue dip to ₹930 Cr and an 8% PAT decline to ₹178 Cr, mainly due to adverse monsoons impacting pesticide demand. However, the financial results for the half-year (H1FY26) saw revenue grow 9% to ₹1,987 Cr, with PAT up 11% to ₹356...